PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
Primary Purpose
Opioid Addiction
Status
Unknown status
Phase
Early Phase 1
Locations
China
Study Type
Interventional
Intervention
Deep brain stimulation:PINS Stimulation System
Sponsored by
About this trial
This is an interventional treatment trial for Opioid Addiction
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years old.
- In accordance with the diagnostic standards of DSM-IV & ICD-10 for addicted and DSM-IV for abstinence.
- Qualitative urine detection for opioids showing positive result.
- Cleared for 8 to 36 hours after their last drug taking.
- Fully understood and signed on informed consent.
Exclusion Criteria:
- Person with consciousness disorder on opioid abstinence, seriously aggressive, heavily dehydrated and intending to commit suicide.
- Patients with serious liver and kidney dysfunction, pulmonary decompensation, or complicated with serious damage in other systems.
- Patients with serious infectious disease.
- Patients with history of serious neurological or psychiatrical diseases.
- Person with history of HIV infection or serious malnutrition.
- Dependent upon and addicted to multiple drugs.
- Attended some other drug trials within one month.
Sites / Locations
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Deep Brain Stimulation
Placebo
Arm Description
Stimulator is ON
Stimulator is OFF
Outcomes
Primary Outcome Measures
Schedule for the Assessment of Negative Symptoms (SANS)
Secondary Outcome Measures
Chronic Hunger Scale
Beck Depression Inventory
Buss & Perry Aggression Questionnaire
Full Information
NCT ID
NCT02282072
First Posted
September 26, 2014
Last Updated
October 13, 2016
Sponsor
Beijing Pins Medical Co., Ltd
Collaborators
Beijing Tiantan Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02282072
Brief Title
PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
Official Title
PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
September 2018 (Anticipated)
Study Completion Date
December 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Beijing Pins Medical Co., Ltd
Collaborators
Beijing Tiantan Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to verify efficacy and safety of a bilateral deep brain stimulation (DBS) of the Nucleus accumbens (NAc) as a treatment option for severe opioid addiction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid Addiction
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Deep Brain Stimulation
Arm Type
Active Comparator
Arm Description
Stimulator is ON
Arm Title
Placebo
Arm Type
Sham Comparator
Arm Description
Stimulator is OFF
Intervention Type
Device
Intervention Name(s)
Deep brain stimulation:PINS Stimulation System
Other Intervention Name(s)
Non-rechargeable Implanted device
Primary Outcome Measure Information:
Title
Schedule for the Assessment of Negative Symptoms (SANS)
Time Frame
6 month
Secondary Outcome Measure Information:
Title
Chronic Hunger Scale
Time Frame
6 month
Title
Beck Depression Inventory
Time Frame
6 month
Title
Buss & Perry Aggression Questionnaire
Time Frame
6 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years old.
In accordance with the diagnostic standards of DSM-IV & ICD-10 for addicted and DSM-IV for abstinence.
Qualitative urine detection for opioids showing positive result.
Cleared for 8 to 36 hours after their last drug taking.
Fully understood and signed on informed consent.
Exclusion Criteria:
Person with consciousness disorder on opioid abstinence, seriously aggressive, heavily dehydrated and intending to commit suicide.
Patients with serious liver and kidney dysfunction, pulmonary decompensation, or complicated with serious damage in other systems.
Patients with serious infectious disease.
Patients with history of serious neurological or psychiatrical diseases.
Person with history of HIV infection or serious malnutrition.
Dependent upon and addicted to multiple drugs.
Attended some other drug trials within one month.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jia Fumin, PhD
Phone
+86 010-59361265
Email
pins_medical@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Li Luming, PhD
Organizational Affiliation
Tsinghua University
Official's Role
Study Chair
Facility Information:
Facility Name
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
310000
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bomin Sun, MD
12. IPD Sharing Statement
Learn more about this trial
PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
We'll reach out to this number within 24 hrs